Merck & Co., Inc. (MRK) Earnings
Merck & Co., Inc.'s most recently reported earnings, recent earnings filings (8-K) and headline annual financials, sourced from SEC EDGAR.
Last reported earnings
Aug 4, 2026
From the latest earnings 8-K
Revenue • FY2025
$65.01B
▲ 1.3%YoY
Diluted EPS • FY2025
$7.28
▲ 8.0%YoY
Reported earnings dates are based on the latest 8-K (Item 2.02) filings. The next earnings date is an estimate projected from MRK's historical reporting pattern, not a company-confirmed date.
Headline financials
| Period | Revenue | Net income | Gross profit | Dil. EPS | Free cash flow | Op. margin | Rev. growth |
|---|---|---|---|---|---|---|---|
| FY2025 | $65.01B | $18.25B | $48.63B | $7.28 | $12.36B | — | +1.3% |
| FY2024 | $64.17B | $17.12B | $48.98B | $6.74 | $18.1B | — | +6.7% |
| FY2023 | $60.12B | $365M | $43.99B | $0.14 | $9.14B | — | +1.4% |
| FY2022 | $59.28B | $14.52B | $41.87B | $5.71 | $14.71B | — | +21.7% |
Recent earnings filings
| Filed | Form | Accession |
|---|---|---|
| Aug 4, 2026 | 8-K (2.02) | 0001104659-26-090045EDGAR |
| Apr 30, 2026 | 8-K (2.02) | 0001104659-26-052081EDGAR |
| Feb 3, 2026 | 8-K (2.02) | 0001104659-26-009495EDGAR |
| Oct 30, 2025 | 8-K (2.02) | 0001104659-25-103974EDGAR |
| Jul 29, 2025 | 8-K (2.02) | 0001104659-25-071380EDGAR |
| Apr 24, 2025 | 8-K (2.02) | 0001104659-25-038301EDGAR |
| Feb 4, 2025 | 8-K (2.02) | 0001104659-25-008863EDGAR |
| Oct 31, 2024 | 8-K (2.02) | 0001104659-24-112841EDGAR |
Earnings for companies related to MRK
Never miss a MRK filing.
Get an email when MRK files its next 8-K, Form 4, 10-K or 10-Q with the SEC. Free, no account needed.
Free foreverNo account requiredOne-click unsubscribe
Data as of Oct 16, 2026Source: SEC EDGAR.